Search for: "SANOFI-AVENTIS (FRANCE)"
Results 1 - 20
of 42
Sort by Relevance
|
Sort by Date
31 Dec 2020, 11:41 pm
The French government wanted to avoid two things:They didn't want Sanofi-Aventis to lose market share, as a result of its failure to provide a competitive COVID-19 vaccine, to German and American companies.They also wanted to avoid a situation in which a German company (founded and led by Turkish immigrants) would have "saved" Europe from COVID-19.So Muckron, probably through French EU fake news commissioner Thierry Breton, practically vetoed any commitment to other… [read post]
10 Oct 2019, 7:35 am
None of its largest corporations (such as LVMH, L'Oréal, and Sanofi-Aventis) is a digital-economy player. [read post]
8 Oct 2019, 1:37 am
Francois Pochart and Thierry LautierThe transposition of the “trade secrets” directive in France allowed the introduction of new legal tools that apply to ex parte investigation measures and infringement seizures (“saisie-contrefaçon”). [read post]
9 Jul 2016, 4:26 am
Sanofi-Aventis is a major pharmaceutical company based out of France that does business all over the world. [read post]
6 Apr 2016, 4:54 pm
” Sanofi-Aventis Warned About Taxotere Baldness Carson alleges that Sanofi-Aventis warned doctors and patients in Europe in 2005 and in Canada 2012 about the risks of permanent hair loss from Taxotere side effects, but failed to provide such warnings to the U.S. patients and doctors until January 2016. [read post]
17 Mar 2016, 8:32 am
Carson, alleges that Sanofi-Aventis failed to adequately warn female breast cancer patients and doctors about the risk of permanent baldness from Taxotere. [read post]
26 Apr 2015, 4:30 am
Music and movie firms back website-blocking in Singapore http://t.co/VyYvVZsIN0 -> Goebbels' estate sues Random House for diary royalties http://t.co/1PDCxZpeuA -> Companies' 'fears are real' with Chinese cyber law http://t.co/4DwKwMLVEx -> European privacy watchdogs join forces to probe Facebook – Oneindia http://t.co/e6M4Q2OEcC -> Computer and Internet Law Weekly Updates for 2015-04-18: blogged: Computer and Internet Law Weekly Updates for…… [read post]
2 Oct 2012, 5:57 am
Sur le plan économique, avec des exportations vers la France de 49,3 M€ et des importations de France de 1 155,4 M€, le Panama est parmi les pays d’Amérique latine, le 3ème pays client de la France et son 16ème pays fournisseur. [read post]
10 Feb 2012, 12:39 pm
In early 2006, Bristol-Myers and France's Sanofi, which at the time was Sanofi-Aventis, reached a confidential settlement with Apotex to pay the Canadian company at least $40 million to delay selling generic Plavix until at least 2011, when the drug's primary patent was to expire. [read post]
24 Aug 2011, 6:26 am
Cambridge was praised for the strong network of bicycle lanes and shared lane space along the Massachusetts institute of Technology (MIT) campus and nearby technology companies, such as Genzyme, Sanofi Aventies, Biogen Idec and Akamai. [read post]
10 Aug 2011, 4:30 am
”: a note on Neurim (The SPC blog) France: The end of the reform on the appearance of generic drugs and IPR (Class 46) Spain: A SHED OF LIGHT IN THE DARK: First Spanish decision admitting post-grant claim limitations under article 138.3 of CPE 2000: Sanofi-Aventis v. [read post]
3 Aug 2011, 3:31 am
Application fee increases by a whopping 19.4% (or almost $300K) (FDA Law Blog) US: Life sciences venture funding up 37% in second quarter (Patent Docs) Products Arava (Leflunomide) – Australia: FCA ‘evergreens’ Arava: Sanofi-Aventis Australia v Apotex (Patentology) Cambia (Diclofenac) – US: Nautilus files patent infringement complaint against Edict Pharmaceuticals in response to Para IV certification filing (Patent Docs) Cenestin – US: CAFC… [read post]
7 Jul 2011, 1:30 pm
In January, sanofi-aventis and the FDA warned that reports of acute liver injury associated with the drug had been received. [read post]
16 Mar 2011, 3:50 am
Abbott: Federal Circuit struggles to articulate a coherent standard for compliance with the Lilly written description requirement (Holman’s Biotech IP Blog) Lexapro (Escitalopram) – US: CAFC affirms obviousness of Infosint’s patent claims (IPBiz) Lotronex (Alosetron) – US: Prometheus files patent infringement suit against Roxane in response to Para IV challenge (Patent Docs) Pravastatine – Belgium/France: Post-expiry saisie-contrefaçon: Belgium and… [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
22 Jan 2011, 4:12 pm
- Sanofi-Aventis SA, France's largest drug maker, will send "Dear Doctor" letters advising that two patients who took its Multaq (Dronedarone) drug for artial fibrillation suffered liver failure. [read post]
29 Dec 2010, 2:57 am
(Spicy IP) Fentanyl – Germany: Supreme Court overrules Federal Patent Court’s restrictive interpretation in case of inconsistency between preamble and claim (EPLAW) Fluvastatine – Belgium: Court of Appeal Brussels preliminarily enjoins Mylan from infringing Novartis’ patent (Kluwer Patent Blog) Glucotrol (Glipizide) – US: Alza files patent infringement complaint against Mylan following Para IV certification filing (Patent Docs) Hectorol (Doxercalciferol) – US:… [read post]
7 Oct 2010, 2:38 pm
Genzyme said Thursday that its board had again rejected an $18.5 billion takeover offer from Sanofi-Aventis of France, saying the bid remains too low. [read post]
13 Sep 2010, 4:45 am
Sanofi-Aventis, France's largest drugmaker, arranged about $10 billion of underwritten loans to back its bid for U.S. biotechnology company Genzyme, two people familiar with the situation said. [read post]
30 Jun 2010, 3:50 am
Sanofi-Aventis, France's largest drugmaker, agreed to buy closely held TargeGen to add treatments for certain forms of leukemia and blood disorders, Bloomberg News reported. [read post]
